Azelastine Hydrochloride Solution/ Drops
Product Images NDC 70069-091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 70069-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B6722959 62fd 4637 94ba 6fe4e1bc45f8 01

FDA Label Image

B6722959 62fd 4637 94ba 6fe4e1bc45f8 02

B6722959 62fd 4637 94ba 6fe4e1bc45f8 02
This is a description of a sterile ophthalmic solution containing Azelastine HCI. The usual dosage is one drop per affected eye twice a day. The product comes in a 6mL bottle and needs to be stored upright between 2 and 25°C. It is for use in the eyes only and requires a prescription. The manufacturer is Somerset Therapeutics, LLC, and the product is made in India. Full prescribing information is available in the packaging insert. No information is available regarding a Varnish Area.*
FDA Label Image

B6722959 62fd 4637 94ba 6fe4e1bc45f8 03

B6722959 62fd 4637 94ba 6fe4e1bc45f8 03
This is a description of a medication called "Azelastine HCI Ophthalmic Solution, USP" manufactured by Somerset Therapeutics LLC. It is a prescription drug used for the treatment of allergic conjunctivitis. It comes as a sterile solution containing 0.5 mg of azelastine hydrochloride per mL, with benzalkonium chloride as a preservative. The recommended dosage is one drop in each affected eye twice daily. The medication should be stored upright between 2°C and 25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.